Related references
Note: Only part of the references are listed.Interleukin-33 Is Expressed in Differentiated Osteoblasts and Blocks Osteoclast Formation From Bone Marrow Precursor Cells
Jochen Schulze et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
IL-33 Shifts the Balance from Osteoclast to Alternatively Activated Macrophage Differentiation and Protects from TNF-α-Mediated Bone Loss
Mario M. Zaiss et al.
JOURNAL OF IMMUNOLOGY (2011)
Inhibition of T Cell-Dependent and RANKL-Dependent Osteoclastogenic Processes Associated With High Levels of Bone Mass in Interleukin-15 Receptor-Deficient Mice
Souad Djaafar et al.
ARTHRITIS AND RHEUMATISM (2010)
Cutting Edge: Mast Cells Express IL-17A in Rheumatoid Arthritis Synovium
Axel J. Hueber et al.
JOURNAL OF IMMUNOLOGY (2010)
Inhibition of Interleukin-6 Receptor Directly Blocks Osteoclast Formation In Vitro and In Vivo
Roland Axmann et al.
ARTHRITIS AND RHEUMATISM (2009)
GM-CSF and IL-4 induce dendritic cell differentiation and disrupt osteoclastogenesis through M-CSF receptor shedding by up-regulation of TNF-α converting enzyme (TACE)
Masahiro Hiasa et al.
BLOOD (2009)
Osteoclasts and Arthritis
Georg Schett et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Mechanisms of Disease: Interleukin-17 and Type 17 Helper T Cells.
Pierre Miossec et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis
Stanley B. Cohen et al.
ARTHRITIS AND RHEUMATISM (2008)
Induction of Osteoclast-Associated Receptor, a Key Osteoclast Costimulation Molecule, in Rheumatoid Arthritis
Sonja Herman et al.
ARTHRITIS AND RHEUMATISM (2008)
Interleukin-6 directly inhibits osteoclast differentiation by suppressing receptor activator of NF-κB signaling pathways
Fumio Yoshitake et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
IL-23 inhibits osteoclastogenesis indirectly through lymphocytes and is required for the maintenance of bone mass in mice
Julian M. W. Quinn et al.
JOURNAL OF IMMUNOLOGY (2008)
IL-23 induces receptor activator of NF-κB ligand expression on CD4+ T cells and promotes osteoclastogenesis in an autoimmune arthritis model
Ji Hyeon Ju et al.
JOURNAL OF IMMUNOLOGY (2008)
TNF-induced structural joint damage is mediated by IL-1
Jochen Zwerina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cytokines in the pathogenesis of rheumatoid arthritis
Iain B. McInnes et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems
Hiroshi Takayanagi
NATURE REVIEWS IMMUNOLOGY (2007)
High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study
Georg Schett et al.
ARCHIVES OF INTERNAL MEDICINE (2006)
Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction
Kojiro Sato et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
M-CSF mediates TNF-induced inflammatory osteolysis
H Kitaura et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
IL-1 mediates TNF-induced osteoclastogenesis
S Wei et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Treatment with a neutralizing anti-murine interleukin-17 antibody after the onset of collagen-induced arthritis reduces joint inflammation, cartilage destruction, and bone erosion
E Lubberts et al.
ARTHRITIS AND RHEUMATISM (2004)
RANK signaling is not required for TNFα-mediated increase in CD11bhi osteoclast precursors but is essential for mature osteoclast formation in TNFα-mediated inflammatory arthritis
P Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism
O Kudo et al.
BONE (2003)
Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis
E Romas et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
IL-6, leukemia inhibitory factor, and oncostatin M stimulate bone resorption and regulate the expression of receptor activator of NF-κB ligand, osteoprotegerin, and receptor activator of NF-κB in mouse calvariae
P Palmqvist et al.
JOURNAL OF IMMUNOLOGY (2002)
RANKL maintains bone homeostasis through c-Fos-dependent induction of interferon-β
H Takayanagi et al.
NATURE (2002)
Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin
K Redlich et al.
ARTHRITIS AND RHEUMATISM (2002)
TRANCE/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis
AR Pettit et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)
IL-12 alone and in synergy with IL-18 inhibits osteoclast formation in vitro
NJ Horwood et al.
JOURNAL OF IMMUNOLOGY (2001)
TNF-α induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand
J Lam et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)
T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ
H Takayanagi et al.
NATURE (2000)
Share Paper
